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Abstract
Introduction: Mediastinitis is one of the most feared
complications for thoracic surgeons, being a significant
factor in morbidity and mortality in thoracic surgery.
Objective: To find a new alternative in order to prevent
mediastinitis, reducing the morbidity and mortality.
Methods: A retrospective study including 1020 patients
operated between February 2002 and October 2005. Patients
underwent bypass surgery and vancomycin paste was used
rather than bone wax in all cases.
Results: Patients were followed-up for 45 months; there
were only five (0.49%) cases of mediastinitis; no deaths were
observed.
Conclusion: The use of Vancomycin paste to replace bone
wax proved to be a great allied to prevent mediastinitis after
thoracic surgery.
Descriptors: Mediastinitis, prevention & control.
Vancomycin. Cardiac surgical procedures.
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INTRODUCTION
Mediastinitis is one of the most feared surgical
complications faced by cardiovascular surgeons, being an
aggravating factor in cases of morbidities and mortalities
in cardiac surgery postoperative period. It affects 0.5% to
5.0% of the patients after a cardiac surgery [1,2]; it may
come to affect 8% of the patients who underwent myocardial
revascularization using both internal thoracic arteries [3].
The risks of mediastinitis increase when factors such
as diabetes, obesity, bilateral internal thoracic artery graft,
cigarette-smoking, pneumonia, surgical re-explorations,
postoperative bleeding, emergency surgeries, and
sustained mechanical ventilation are aggregated [4,5].
The main signs and symptoms evidenced by
mediastinitis are: fever, leukocytosis, surgical wound with
the presence of hyperemia, pain, and drainage of purulent
exudates. The diagnosis will be more accurate through
radiographic testing, especially computed tomography with
visualization of retrosternal fluid collection; however, the
harvesting of the material through sternal puncture results
in a definitive diagnosis [4,6].
The factor of greatest significance to the success of
mediastinitis treatment is the early diagnosis and
therapeutics [7]. Diagnosing the infectious process before
patient discharge to establish an early and adequate therapy
interferes decisively to infection control and decrease of
death cases caused by mediastinitis [8].
In this way, the aim of this study was to use vancomycin
paste on the sternum during surgical procedure in order to
prevent mediastinitis targeting a better survival index in
patients undergoing cardiac surgery.
METHODS
This was a retrospective study with 1,020 adult patients
who underwent surgery with cardiopulmonary bypass
support at the Hospital dos Fornecedores de Cana
Piracicaba Cardiac Surgery Service from February 2002 to
October 2005.
Vancomycin paste was used in all the patients for
sternum hemostasis and mediastinitis prophylaxis.
In view of the nature of the study, this method of
homeostasis has already been used in other disciplines,
such as orthopedics, informed consent from the patients
or the next of kin was waived.
Thirty patients were excluded if the data were incomplete
or due to death in the first five days postoperatively of
noninfectious cause.
In a series of 592 patients (58%) undergoing coronary
artery bypass grafting (CABG), 357 patients (35%)
underwent surgery to correct valve defects and 71 (7%)
underwent several other surgeries. Six hundred and ninety-
four patients (68%) were male and 326 (32%) female.
Patients’ age varied from 35 to 84 years, with a mean age
of 59.5 years.
Patients’ follow-up was performed throughout the
hospitalizations days prior to surgery. A new visit to the
outpatient clinic was scheduled 10 days after the patient
discharge. Patients who presented any kind of
complications, such as arrhythmia, pleural effusion,
pneumonia, heart failure, blood pressure abnormalities,
fever to be explained, inflammatory and/or infectious
processes of sternotomy or saphenectomy scars, and
other morbidities were followed-up for an indefinite length
of time.
All patients were given cephaxolin, 1 g intravenous in
the moment of anesthetic induction, and every 8 hours for
48 hours. Patients who presented infectious processes,
such as pneumonia and urinary tract infection
postoperatively received specific antibiotic treatment for a
longer period.
The criteria used to establish the diagnosis of
mediastinitis resulting from the signs and symptoms were
the following: fever, hyperemia of the sternotomy scar, skin
and subcutaneous tissue dehiscence, thoracic pain, sternal
instability, presence of secretion in the surgical wound,
leukocytosis, and worsening of the general health status.
We considered that two or more of these signs are sufficient
to make a diagnosis of the infectious process establishing
Resumo
Introdução: A mediastinite é uma das complicações mais
temidas pelos cirurgiões cardiovasculares, sendo esta um
fator importante na morbidade e mortalidade em cirurgia
cardíaca.
Objetivo: Buscar uma nova opção na prevenção da
mediastinite, diminuindo o índice de morbidade e
mortalidade.
Métodos: Estudo retrospectivo que incluiu 1020 pacientes
submetidos a cirurgia cardíaca, no período de fevereiro de
2002 a outubro de 2005. Os pacientes foram submetidos a
cirurgia com uso de circulação extracorpórea e
implementação da vancomicina em pasta em substituição a
cera de osso.
Resultados: Os pacientes foram seguidos ao longo de 45
meses, apenas cinco (0,49%) desenvolveram mediastinite e
não houve óbito.
Conclusão:  O uso de vancomicina em pasta em
substituição à cera de osso mostrou-se ser uma aliada na
prevenção da mediastinite no pós-operatório de cirurgia
cardíaca.
Descritores: Mediastinite, prevenção & controle.
Vancomicina. Procedimentos cirúrgicos cardíacos.
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in the median thoracotomy site and to institute an immediate
treatment. Surgical wound infections successful treatment
of sternotomy is related to the diagnosis and to the
beginning of the treatment in the earliest phase as possible.
In the current study, we considered only the patients
who presented infections affecting skin, subcutaneous
tissue, sternum, and both superior and inferior mediastinum.
Antibiotic via intramuscular (vancomycin associated to
imipenem) were administered to all patients; the patients
were submitted to surgical treatment with cleaning of the
infected site, sternal debridement, and Robicsek resuture
of the sternum.
Vancomycin paste: application and preparation
techniques
2 x 500 mg vancomycin vials, plus 1 milliliter of normal saline;
Use a stainless steel sink to make the preparation;
Vancomycin paste is prepared at the moment of
sternotomy and should be applied immediately.
In 2 out of 5 cases, the diagnosis of mediastinitis was
made before the patient discharge; in the remaining patients,
the diagnosis was made after postoperative consultation
and the mean diagnosis time was 13 days.
Patients, who developed mediastinitis, were treated with
early surgical intervention, cleaning the infected site, sternal
debridement, and Robicsek resuture of the sternum; suction
drains were placed in the mediastinum and over the sternum.
Patients were treated with intravascular antibiotic
(vancomycin associated with imipenem); this made possible
the diagnosis of mediastinitis.
In the intraoperative period culture, Stafilococcus aureus
was predominant in three patients (60%), Pseudomonas
aeruginosa in one case (20%), and one culture (20%) was
negative.
The major difficulty in the treatment of mediastinitis is
the prolonged hospitalization time; the mean hospitalization
time was 20 days; the first three patients had more than one
hospitalization for treatment of mediastinitis. No death
occurred due to mediastinitis.
DISCUSSION
Mediastinitis is a complication of difficult and long-
term treatment involving a high hospital cost; in some cases,
mediastinitis even provides, in a way, a difficult physician-
patient-hospital relationship due to both treatment and
uncertainties caused by the long-term treatment.
The greatest incidence of complications is from 10 to 20
day postoperatively. Complications affect mainly the
patients who underwent coronary artery bypass grafting
(50%), valve replacement (20%), aortic diseases (20%), and
other surgeries (10%).
According to the literature, the isolated bacteria, in most
cases, are Staphylococcus aureus (45%), Pseudomonas
aeruginosa (25%), and Escherichia coli (10%). The success
of the treatment is increased when the isolated bacterium is
the Staphylococcus aureus [4].
Despite affecting a small number of patients, mortality
rate is high reaching as high as 47% [9].
Minimally invasive surgery and off-pump CABG are
important factors in the decrease of mediastinitis events
because both surgeries reduce surgical trauma and
provide a faster patient recovery [10,11]. The use of more
efficient antibiotics has also been described as an
important factor to control mediastinitis. However, it is
known that there is less systemic antibiotic penetration
into the bone tissue [12,13].
Several prophylactic measures both in hospital and
outpatient clinic period have also proven to be effective in
controlling incisional infections: three baths with
chlohexidine, an antiseptic/germicide/disinfectant, in the
first 24 hours prior to surgery; access through the opening
Fig. 1 – Preparation of vancomycin paste
RESULTS
The survey of 1,020 patients showed that there have been
only five cases (0.49%) of mediastinitis. Cardiopulmonary
bypass time was long in all patients with mediastinitis; mean
cardiopulmonary bypass time was 115 minutes.
Patients who presented mediastinitis have been
submitted to coronary artery bypass grafting using the left
internal thoracic artery (LITA). Diabetes was the second
most found risk factor. Four patients (80%) were diabetics
and insulin-dependent.
On the average, we used three grafts per surgery; in
one case a left ventricle aneurysm was repaired.
ARRUDA, MVF ET AL - The use of the vancomycin paste for
sternal hemostasis and mediastinitis prophylaxis
Rev Bras Cir Cardiovasc 2008; 23(1): 35-39
38
of gastric probe and the thermometer; replacement of PVPI
by chlohexidine in the skin antisepsis (disinfection); tight
glycemic control; use of based-antibiotic ointments over
the incisions; early antibiotic therapy in cases of hyperemia
and excretion, and a new consultation if early signs of
infections are seen after patient discharge [14].
At the beginning of the study we have had difficulties
to standardize the amount of vancomycin needed to recover
both sternal margins and to determine the adequate moment
to prepare the paste.
Moreover, we have also had difficulties to settle the
amount of physiologic saline to give consistency to the
paste. Reviewing the literature we have found an article in
which a vial of vancomycin (500 mg) was dissolved in a 10
mL normal saline [15]. In our service, we used only 1 mL of
normal saline to meet a pasty consistency, thus posing
both bacteriostatic and hemostatic effect in the medullary
portion of the sternum without antibiotic loss through
mediastinal drains.
In a multivariate analysis of the risk factors for
mediastinitis by the Instituto Dante Pazzanese de
Cardiologia, it was verified that the most important risk
factors related to the patient are obesity and cigarette-
smoking; the most important risk factors related to the
postoperative period are the length of stay in the ICU and
infection at another site [16].
New alternatives are being searched in order to reduce
the incidence of mediastinitis. Among them, the minimally
invasive surgery is an option because it reduces hospital
length of stay postoperatively. The use of a topical
antibiotic, such as gentamicin-collagen under the sternum,
which has been recommended by the Helsinki University
Central Hospital Group, Helsinki, Finland, provided a
reduction in the mediastinitis events [17].
A datum of great interest is to know whether the
vancomycin in a topical dose of 1 mg is reaching systemic
levels to avoid the development of the Stafilococcus
aureus. We know that if the levels are not being reached,
there will be a risk of bacterial resistance. The article
published by the Journal of Cardiothoracic Surgery, on
January 2003, reports that the use of vial of vancomycin
(500 mg) dissolved in a 10 mL normal saline applied at the
moment of sternotomy closure was not capable of reaching
levels needed to avoid bacterial growth and would be
potentializing the appearance of resistant Stafilococcus
aureus [15].
Articles published to elsewhere have confirmed the
efficacy of vancomycin as a bone infection prophylactic
factor, especially when applied topically [18-20]. Studies
have shown that the application of vancomycin associated
to orthopedic cement used in hip prosthesis reduced the
number of infections, and it was also important in the
treatment of infected re-operations [21]. We have sought
with this new method of homeostasis, to reduce the
incidence of sternal infection once the bone wax, especially
when applied abusively is one more factor to be summed
up to infection arouse [22].
Bone wax has a hemostatic property which can lead to
an important decrease of the vascularization of the sternum.
Moreover, it is not easily absorbable by the organism,
prolonging the bone ischemia over several days. These
factors contribute in a negative way to bone consolidation.
Based on the low-infection rate presented by our
patients, we believe that using the vancomycin paste we
are avoiding one more risk factor, thus reducing the rate of
mediastinitis in postoperative cardiac surgery patients.
CONCLUSIONS
In our Service, we have been using vancomycin rather
bone wax since 2002. Our rate of mediastinal infection is
nearly 0.49%. When comparing this rate with those found
in the literature, we have come to a conclusion that the
studied populations are similar, as well as the pre- and
intraoperative factors for mediastinitis, and the sole
differentiated factor is the use of vancomycin paste. This
led us to believe that vancomycin paste in a dose of 1 g is
effective in the prophylaxis of sternum infection and,
consequently, of mediastinum infection.
We are beginning a new randomized study with a control
group aiming at studying our local population in which we
can analyze these data more clearly and to highlight the
efficacy of the vancomycin paste for sternal hemostasis
and mediastinitis prophylaxis with the main goal of giving
cardiovascular surgeons a new hope in reducing the
mortality and morbidity rates of particular cause, such as
mediastinitis.
We are sure that only with the persistence in searching
the scientific knowledge, the answer to the solution of
this problematic experienced by all cardiovascular
surgeons will be found.
REFERENCES
1. Fonkalsrud EW. Chest wall abnormalities. In: Glenn WWL,
ed. Glenn’s thoracic end cardiovascular surgery. 6th ed. vol. 1.
Stanford:Appleton & Lange;1996. p.581-92.
ARRUDA, MVF ET AL - The use of the vancomycin paste for
sternal hemostasis and mediastinitis prophylaxis
Rev Bras Cir Cardiovasc 2008; 23(1): 35-39
39
2. Rupp ME. Mediastinitis. In: Mandell R, ed. Mandell principles
and infectious diseases. 5th ed. Churchill:Churchill
Livingstone;2000. p.941-9.
3. Kirklin/Barratt - Boyes. Cardiac surgery. 3a ed.
Philadelphia:Churchill Livingstone;2003. p.230.
4. Souza VC, Freire ANM, Tavares Neto J. Mediastinite pós-
esternotomia longitudinal para cirurgia cardíaca: 10 anos de
análise. Rev Bras Cir Cardiovasc. 2002;17(3):266-70.
5. Jakicic JM, Wing RR, Butler BA, Robertson RJ. Prescribing
exerercise in multiple short bouts versus one continuous bout:
effects on adherence, cardiorespiratory fitness, and weight loss
in overweight women. Int J Obes Relat Metab Disord.
1995;19(12):893-901.
6. Guaragna JC, Facchi LM, Baião CG, Cruz IBM, Bodanese
LC, Albuquerque L, et al. Preditores de mediastinite em cirurgia
cardíaca. Rev Bras Cir Cardiovasc. 2004;19(2):165-70.
7. Merrill WH, Akhter SA, Wolf RK, Schneeberger EW, Flege JB
Jr. Simplified treatment of postoperative mediastinitis. Ann
Thorac Surg. 2004;78(2):608-12.
8. Schimin LC, Batista RL, Mendonça FCC. Mediastinite no
Hospital de Base do Distrito Federal: incidência em seis anos.
Rev Bras Cir Cardiovasc. 2002;17(2):36-9.
9. El Oakley RM, Wright JE. Postoperative mediastinitis:
classification and management. Ann Thorac Surg.
1996;61(3):1030-6.
10. Barbero-Marcial M, Tanamati C, Jatene MB, Atik E, Jatene
AD. Transxiphoid approach without median sternotomy for
the repair of atrial septal defects. Ann Thorac Surg.
1998;65(3):771-4.
11. Calafiore AM, Giamarco GD, Teodori G, Bosco G,
D’Annunzio E, Barsotti A, et al. Left anterior descending
coronary artery grafting via left anterior small thoracotomy
without cardiopulmonary bypass. Ann Thorac Surg.
1996;61(6):1658-63.
12. Rosin H, Rosin AM, Krämer J. Determination of antibiotic
levels in human bone. I. Gentamicin levels in bone. Infection.
1974;2(1):3-6.
13. Smilack JD, Flittie WH, Williams TW Jr. Bone concentrations
of antimicrobial agents after parenteral administration.
Antimicrob Agents Chemother. 1976;9(1):169-71.
14. Antoniali F, Costa CE, Tarelho LS, Lopes MM, Albuquerque
APN, Reinert GAA, et al. O impacto de mudanças nas medidas
de prevenção e no tratamento de infecções incisionais em cirurgia
de revascularização do miocárdio. Rev Bras Cir Cardiovasc.
2005;20(4):382-91.
15. Desmond J, Lovering A, Harle C, Djorevic T, Millner R. Topical
vancomycin applied on closure of the sternotomy wound does
not prevent high levels of systemic vancomycin. Eur J
Cardiothorac Surg. 2003;23(5):765-70.
16. Abboud CS, Wey SB, Baltar VT. Risk factors for mediastinitis
after cardiac surgery. Ann Thorac Surg. 2004;77(2):676-83.
17. Eklund AM, Valtonen M, Werkkala KA. Prophylaxis of sternal
wound infections with gentamicin-collagen implant:
randomized controlled study in cardiac surgery. J Hosp Infect.
2005;59(2):108-12.
18. Vander Salm TJ, Okike ON, Pasque MK, Pezzella AT, Lew R,
Traina V, et al. Reduction of sternal infection by application of
topical vancomycin. J Thorac Cardiovasc Surg.
1989;98(4):618-22.
19. Chohfi M. O cimento ortopédico associado a vancomicina.
Estudo de seu comportamento mecânico e da difusão do
antibiótico em meio líquido. Rev Bras Ortop. 1994;29:363-70.
20. Massias L, Dubois C, Lentdecker P, Brodaty O, Fischler M,
Farinotti R. Penetration of vancomycin in uninfected sternal
bone. Antimicrob Agents Chemother. 1992;36(11):2539-41.
21. Buchholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic
cement: current concepts. Clin Orthop Relat Res.
1984;(190):96-108.
22. Harjula A, Järvinen A. Postoperative median sternotomy
dehiscence. Scand J Thorac Cardiovasc Surg. 1983;17(3):277-81.
ARRUDA, MVF ET AL - The use of the vancomycin paste for
sternal hemostasis and mediastinitis prophylaxis
Rev Bras Cir Cardiovasc 2008; 23(1): 35-39
